scholarly journals Evidence for Activation of AMP Kinase (AMPK) in Nephropathic Cystinosis

2012 ◽  
Vol 26 (S1) ◽  
Author(s):  
Mary Taub ◽  
Facundo Cutuli
Antioxidants ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 776
Author(s):  
Elzbieta Janda ◽  
Concetta Martino ◽  
Concetta Riillo ◽  
Maddalena Parafati ◽  
Antonella Lascala ◽  
...  

Dietary flavonoids stimulate autophagy and prevent liver dysfunction, but the upstream signaling pathways triggered by these compounds are not well understood. Certain polyphenols bind directly to NRH-quinone oxidoreductase 2 (NQO2) and inhibit its activity. NQO2 is highly expressed in the liver, where it participates in quinone metabolism, but recent evidence indicates that it may also play a role in the regulation of oxidative stress and autophagy. Here, we addressed a potential role of NQO2 in autophagy induction by flavonoids. The pro-autophagic activity of seven flavonoid aglycons correlated perfectly with their ability to inhibit NQO2 activity, and flavones such as apigenin and luteolin showed the strongest activity in all assays. The silencing of NQO2 strongly reduced flavone-induced autophagic flux, although it increased basal LC3-II levels in HepG2 cells. Both flavones induced AMP kinase (AMPK) activation, while its reduction by AMPK beta (PRKAB1) silencing inhibited flavone-induced autophagy. Interestingly, the depletion of NQO2 levels by siRNA increased the basal AMPK phosphorylation but abrogated its further increase by apigenin. Thus, NQO2 contributes to the negative regulation of AMPK activity and autophagy, while its targeting by flavones releases pro-autophagic signals. These findings imply that NQO2 works as a flavone receptor mediating autophagy and may contribute to other hepatic effects of flavonoids.


Author(s):  
Yawen Lu ◽  
Jingjie Ma ◽  
Ping Li ◽  
Baolin Liu ◽  
Xiaodong Wen ◽  
...  
Keyword(s):  

Diabetes ◽  
2007 ◽  
Vol 56 (9) ◽  
pp. 2228-2234 ◽  
Author(s):  
G. S. Eng ◽  
R. A. Sheridan ◽  
A. Wyman ◽  
M. M.-Y. Chi ◽  
K. P. Bibee ◽  
...  

JAMA ◽  
1993 ◽  
Vol 270 (18) ◽  
pp. 2200 ◽  
Author(s):  
Demetrios S. Theodoropoulos

1986 ◽  
Vol 237 (1) ◽  
pp. 9-15 ◽  
Author(s):  
F Tietze ◽  
L H Rome ◽  
J D Butler ◽  
G S Harper ◽  
W A Gahl

Cultured fibroblasts from patients with I-cell disease (mucolipidosis II) accumulate excessive amounts of free cystine, similarly to cells from patients with nephropathic cystinosis, a disorder of lysosomal cystine transport. To clarify whether the intralysosomal accumulation of cystine in I-cell-disease fibroblasts was due to a defective disposal mechanism, we measured the rates of clearance of free [35S]cystine from intact normal, cystinotic and I-cell-disease fibroblasts. Loss of radioactivity from the two mutant cell types occurred slowly (t 1/2 = 500 min) compared with the rapid loss from normal cells (t 1/2 = 40 min). Lysosome-rich granular fractions isolated from three different cystine-loaded normal, cystinotic and I-cell-disease fibroblast strains were similarly examined for non-radioactive cystine egress. Normal granular fractions lost cystine rapidly (mean t 1/2 = 43 min), whereas cystinotic granular fractions did not lose any cystine (mean t 1/2 = infinity). I-cell-disease granular fractions displayed prolonged half-times for cystine disposal (mean = 108 min), suggesting that I-cell-disease fibroblasts, like cystinotic cells, possess a defective carrier mechanism for cystine transport.


Neuroscience ◽  
2016 ◽  
Vol 330 ◽  
pp. 219-228 ◽  
Author(s):  
Ke-Zhong Shen ◽  
Yan-Na Wu ◽  
Adam C. Munhall ◽  
Steven W. Johnson

1987 ◽  
Vol 105 (12) ◽  
pp. 1670-1671 ◽  
Author(s):  
B. Katz ◽  
R. B. Melles ◽  
J. A. Schneider

Sign in / Sign up

Export Citation Format

Share Document